A marker related to auxiliary diagnosis of non-small cell lung cancer and its application
A non-small cell lung cancer, diagnostic marker technology, applied in the biological field, can solve the problems of unclear role of human tumors, no human cancer detection and target therapy, and low early diagnosis rate.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0046] The present invention uses Real-time PCR and immunohistochemical technology to analyze the expression level of NATD in the tumor specimens and normal tissues of 29 cases of non-small cell lung cancer patients, and finds that the expression level of NATD in the tumor tissues of lung cancer patients is significantly increased, and positively correlated with patient mortality. A stable non-small cell lung cancer cell line with NATD knockdown was constructed, and the migration ability of cancer cells was detected to be impaired. Immunohistochemistry and Real-time PCR detection showed that NATD can regulate the expression of key molecular genes in the process of EMT, and the decrease of NATD expression level can inhibit the conversion process of EMT. NATD without catalytic activity (abbreviated as NATDΔ) was constructed using mutation technology, and in vitro acetylation experiments verified the necessity of the missing acetyl-CoA binding site for the biological activity of ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


